Equity - Narrative (Details)	3 Months Ended
	Mar. 31, 2026 USD ($) $ / shares shares	Mar. 31, 2025 USD ($) shares	Dec. 31, 2025 USD ($) shares	Aug. 31, 2022 shares
Equity [Line Items]
Authorized amount (in shares)				2,000,000
Average cost per share (in dollars per share) | $ / shares	$ 48.70
Shares remaining available for repurchase (in shares)	968,651
Unsettled repurchases | $	$ 0
Preferred shares, convertible preferred, shares outstanding (in shares)	1,935,400		1,935,400
Preferred shares, liquidation preference | $	$ 96,770,000		$ 96,770,000
Common Shares
Equity [Line Items]
Repurchase of common shares (in shares)	324,586	0
Preferred shares - Series C
Equity [Line Items]
Preferred shares, convertible preferred, shares outstanding (in shares)	1,935,400
Preferred stock, dividend per annum (in dollars per share) | $ / shares	$ 3.25
Preferred shares, liquidation preference | $	$ 96,770,000
Convertible preferred stock, conversion ratio (in shares)	0.487
Preferred stock conversion, threshold conversion price percentage (at least)	1.25
At-The-Market Program
Equity [Line Items]
Sale of stock, authorized amount (up to) | $	$ 350,000,000
Trustee
Equity [Line Items]
Grant date fair value | $	$ 244,000	$ 225,000
Trustee | Common Shares
Equity [Line Items]
Number of shares granted (in shares)	5,085	4,855